Table 1 Details of the IQSEC2 variants identified in the 47 patients reported in this study

From: IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients

Patient ID

Sex M/F

Variant position (hg19)

Change (NM_001111125.2)

CADD score (PHRED)

Prediction SIFT/Polyphen-2 (missense)

Protein domain (missense)

Inheritance

Adjusted ACMG variant classification (InterVar)

Novel (n)/ Reference

1

F

g.53350171_53350267delinsAT

c.55_151delinsAT, .(Ala19Ilefs*32)

  

De novoa

Pathogenic

n

2

M

g.53350225G>A

c.97C>T, p.(Gln33*)

36

  

De novoa

Pathogenic

n

3

M

g.53350138G>A

c.184C>T, p.(Arg62*)

35

  

De novoa

Pathogenic

n

4

M

g.53349712_53349734del

c.588_610del, p.(Arg197Alafs*34)

  

De novoa

Pathogenic

n

5

M

g.53285244C>T

c.738-1G>A, p.?

25.4

  

Maternal

Pathogenic

n

6

M

g.53285244C>T

c.738-1G>A, p.?

25.4

  

Maternal

Pathogenic

n

7

M

g.53285244C>G

c.738-1G>C, p.?

25.2

  

De novo

Pathogenic

n

8

F

g.53285177del

c.804delC, p.(Tyr269Thrfs*3)

  

De novoa

Pathogenic

n

9

M

g.53285177del

c.804delC, p.(Tyr269Thrfs*3)

  

De novo

Pathogenic

n

10

M

g.53285177del

c.804delC, p.(Tyr269Thrfs*3)

  

De novoa

Pathogenic

33

11

F

g.53285127del

c.854del, p.(Pro285Leufs*21)

32

  

De novoa

Pathogenic

n

12

M

g.53285086G>A

c.895C>T, p.(Gln299*)

35

  

De novoa

Pathogenic

33

13

M

g.53280352_53280353del

c.1405_1406del, p.(Lys469Valfs*4)

  

De novoa

Pathogenic

n

14

M

g.53280248G>A

c.1510C>T, p.(Gln504*)

37

  

Unknown

Pathogenic

n

15

M

g.53279559_53280191delinsGCC

c.1567_2199delinsGGC, p.(Thr523_Thr733delinsGly)

  

De novoa

Pathogenic

n

16

F

g.53279995_53280014del

c.1744_1763del, p.Arg582Cysfs*9

  

De novo

Pathogenic

n

17

F

g.53279758_53279776del

c.1983_1999del, p.(Leu662Glnfs*25)

  

Unknown

Pathogenic

n

18

F

g.53279680del

c.2078delG, p.(Gly693Valfs*29)

  

Unknown

Pathogenic

n

19

F

g.53279486G>A

c.2272C>T, p.(Arg758*)

35

  

De novo

Pathogenic

n

20

F

g.53279486G>A

c.2272C>T, p.(Arg758*)

35

  

De novoa

Pathogenic

n

21

F

g.53279480C>T

c.2278G>A, p.(Gly760Ser)

32

Tolerated/probably damaging

SEC7

De novoa

Likely pathogenic

n

22

F

g.53278050C>T

c.2312G>A, p.(Gly771Asp)

29.1

Deleterious/probably damaging

SEC7

De novoa

Likely pathogenic

28

23

F

g.53278045G>A

c.2317C>T, p.(Gln773*)

41

  

Unknown

Pathogenic

n

24

F

g.53278030_53278045del

c.2317_2332del, p.(Gln773Glyfs*25)

  

Unknown

Pathogenic

n

25

M

g.53278008G>A

c.2354C>T, p.(Pro785Leu)

29.8

Deleterious/possibly damaging

SEC7

De novo

Likely pathogenic

n

26

M

g.53272627G>A

c.2776C>T, p.(Arg926*)

40

  

De novoa

Pathogenic

n

27

F

g.53272549G>A

c.2854C>T, p.(Gln952*)

41

  

De novoa

Pathogenic

n

28

M

g.53271019G>A

c.2962C>T, p.(Gln988*)

42

  

De novoa

Pathogenic

n

29

F

g.53268413del

c.3079delC, p.(Leu1027Serfs*75)

  

De novo

Pathogenic

n

30

M

g.53267441G>A

c.3163C>T, p.(Arg1055*)

41

  

Maternal

Pathogenic

33

31

F

g.53267441G>A

c.3163C>T, p.(Arg1055*)

41

  

Unknown

Pathogenic

n

32

M

g.53267441G>A

c.3163C>T, p.(Arg1055*)

41

  

De novoa

Pathogenic

n

33

M

g.53267398C>G

c.3206G>C, p.(Arg1069Pro)

34

Tolerated/probably damaging

PH

Maternal

Likely pathogenic

n

34

M

g.53267325A>C

c.3277+2T>G, p.?

24.2

  

De novoa

Pathogenic

n

35

M

g.53267322C>T

c.3277+5G>A, p.?

19.41

  

Maternal

Likely pathogenic

n

36

F

g.53265677G>T

c.3278C>A, p.(Ser1093*)

42

  

De novoa

Pathogenic

n

37

M

g.53265568G>T

c.3387C>A, p.(Tyr1129*)

36

  

De novo

Pathogenic

27

38

M

g.53265522G>A

c.3433C>T, p.(Arg1145*)

37

  

De novoa

Pathogenic

n

39

F

g.53265522G>A

c.3433C>T, p.(Arg1145*)

37

  

Not detected in mother, father unavailable

Likely pathogenic

n

40

F

g.53265009del

c.3457del, p.(Arg1153Glyfs*244)

  

De novoa

Pathogenic

n

41

F

g.53263829dup

c.4039dup, p.(Ala1347Glyfs*40)

  

De novoa

Pathogenic

n

42

F

g.53263467del

c.4401del, p.(Gly1468Alafs*27)

  

Not detected in mother, father unavailable

Likely pathogenic

n

43

M

g.53272651C>A

c.2752G>T, p.(Val918Phe)

34

Deleterious/possibly damaging

SEC7

Maternal

VUS

n

44

F

g.53265540C>T

c.3415G>A, p.(Ala1139Thr)

32

Tolerated/probably damaging

C-ter

Affected sister also has thepathogenic variant, an affected brother deceased (carrier status unknown); parents unavailable

VUS

n

45

M

g.53265003G>A

c.3463C>T, p.Arg1155Trp

32

Deleterious/probably damaging

C-ter

Maternal

VUS

n

46

M

g.53265003G>A

c.3463C>T, p.Arg1155Trp

32

Deleterious/probably damaging

C-ter

Maternal

VUS

n

47

F

g.53310692del

c.737+10385del, p.?

8.355

  

Maternal

VUS

n

  1. ACMG American College of Medical Genetics and Genomics, VUS variant of uncertain significance
  2. aIndicates that paternity and maternity have been confirmed